The past decade has seen many notable contributions to bladder cancer research. Here, we highlight the international efforts in the field, with findings from Europe, USA and China, as well as papers resulting from international cooperation. We anticipate the next 10 years will see even greater collaborative and international efforts.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Integrative multi-omics analysis of muscle-invasive bladder cancer identifies prognostic biomarkers for frontline chemotherapy and immunotherapy
Communications Biology Open Access 17 December 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Dyrskjøt, L. et al. Identifying distinct classes of bladder carcinoma using microarrays. Nat. Genet. 33, 90–96 (2003).
Lee, J. K. et al. A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery. Proc. Natl Acad. Sci. USA 104, 13086–13091 (2007).
van Rhijn, B. W. et al. Combined microsatellite and FGFR3 mutation analysis enables a highly sensitive detection of urothelial cell carcinoma in voided urine. Clin. Cancer Res. 9, 257–263 (2003).
Beecken, W. D. et al. Robotic-assisted laparoscopic radical cystectomy and intra-abdominal formation of an orthotopic ileal neobladder. Eur. Urol. 44, 337–339 (2003).
Grossman, H. B. et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N. Engl. J. Med. 349, 859–866 (2003).
von der Maase, H. et al. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer. J. Clin. Oncol. 23, 4602–4608 (2005).
International Bladder Cancer Nomogram et al. Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. J. Clin. Oncol. 24, 3967–3972 (2006).
Miyamoto, H. et al. Promotion of bladder cancer development and progression by androgen receptor signals. J. Natl Cancer Inst. 99, 558–568 (2007).
Killela, P. J. et al. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc. Natl Acad. Sci. USA, 110, 6021–6026 (2013).
Guo, G. et al. Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation. Nat. Genet. 45, 1459–1463 (2013).
Acknowledgements
D.T. is supported in part by NIH grants CA075115 and CA104106. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Costello, J., Theodorescu, D. International progress: from cytology to genomics. Nat Rev Urol 11, 609–610 (2014). https://doi.org/10.1038/nrurol.2014.236
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2014.236
